| JNTL Consumer Health II (Switzerland) GmbH - Livostin Augentropfen, Augentropfensuspension |
| 50496 | | 01 | | Livostin Augentropfen | | Augentropfensuspension | | S01GX02 | | Levocabastin | | 28.02.1992 | | |
|
| Composition |
| levocabastinum 0.5 mg ut levocabastini hydrochloridum, propylenglycolum, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 9.5 mg, benzalkonii chloridum 0.15 mg, hypromellosum, polysorbatum 80, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Augentropfensuspension | | | | | | | | Principe actif | Concentr. |
|---|
| Levocabastine | 0.5 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Levocabastine | 0.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Benzalkonium Chlorure | 0.15 mg/ml | | Dinatrii Edetas | | | Disodium Phosphate | | | Hypromellosum | | | Sodium Dihydrogenophosphate Monohydrate | | | Polysorbatum 80 | | | Propylenglycol | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 023 | 4 ml | 7.22 | 13.35 | D | LS | Oui |
|
